AI & Biopharma: Demystifying The Hype From Reality

​As part of Seattle AI Week, SeaHealthTech and CDL have partnered to present a thought-provoking event that brings together leading voices from academia, venture capital, and industry. The conversation will explore where healthcare spending is most inefficient and how artificial intelligence is reshaping drug discovery.

​​Our panelists will share complementary perspectives—ranging from big-picture analyses of healthcare financing, to investor priorities in life sciences and AI, to industry insights on bringing new therapies to market. The discussion will move beyond the buzz to examine where AI can truly drive value in healthcare and drug development.

​​Speaker:

• ​​Joseph Dieleman, PhD - Professor of Health Metrics Sciences, IHME, University of Washington

​​Panelists:

• ​​Eva Yin, PhD, MPH, JD - Partner at Wilson Sonsini Goodrich & Rosati

• ​​Joe Horsman, PhD - Investor, Madrona Venture Group

• ​​Jason Fontana, PhD & Co-Founder, Wayfinder Biosciences

• ​​Sara Dutta PhD - Director, Data Science, Novo Nordisk

​​Moderated by Bulat Idrisov, MD, PhDc - Venture Manager, Creative Destruction Lab.